MFDS clears Curocell’s anbal-cel as first homegrown CAR T therapy
MFDS clears Curocell’s anbal-cel as first homegrown CAR T therapy
本文は利用できません。元の情報源をご確認ください。
MFDS clears Curocell’s anbal-cel as first homegrown CAR T therapy
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.